scholarly journals The Development of Polylactic Acid/Multi-Wall Carbon Nanotubes/Polyethylene Glycol Scaffolds for Bone Tissue Regeneration Application

Polymers ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 1740
Author(s):  
Shih-Feng Wang ◽  
Yun-Chung Wu ◽  
Yu-Che Cheng ◽  
Wei-Wen Hu

Composite electrospun fibers were fabricated to develop drug loaded scaffolds to promote bone tissue regeneration. Multi-wall carbon nanotubes (MWCNTs) were incorporated to polylactic acid (PLA) to strengthen electrospun nanofibers. To modulate drug release behavior, different ratios of hydrophilic polyethylene glycol (PEG) were added to composite fibers. Glass transition temperature (Tg) can be reduced by the incorporated PEG to enhance the ductility of the nanofibers. The SEM images and the MTT results demonstrated that composite fibers are suitable scaffolds for cell adhesion and proliferation. Dexamethasone (DEX), an osteogenic inducer, was loaded to PLA/MWCNT/PEG fibers. The surface element analysis performed by XPS showed that fluorine of DEX in pristine PLA fibers was much higher than those of the MWCNT-containing fibers, suggesting that the pristine PLA fibers mainly load DEX on their surfaces, whereas MWCNTs can adsorb DEX with evenly distribution in nanofibers. Drug release experiments demonstrated that the release profiles of DEX were manipulated by the ratio of PEG, and that the more PEG in the nanofibers, the faster DEX was released. When rat bone marrow stromal cells (rBMSCs) were seeded on these nanofibers, the Alizarin Red S staining and calcium quantification results demonstrated that loaded DEX were released to promote osteogenic differentiation of rBMSCs and facilitate mineralized tissue formation. These results indicated that the DEX-loaded PLA/MWCNT/PEG nanofibers not only enhanced mechanical strength, but also promoted osteogenesis of stem cells via the continuous release of DEX. The nanofibers should be a potential scaffold for bone tissue engineering application.

RSC Advances ◽  
2015 ◽  
Vol 5 (97) ◽  
pp. 79703-79714 ◽  
Author(s):  
Hengsong Shi ◽  
Qi Gan ◽  
Xiaowei Liu ◽  
Yifan Ma ◽  
Jun Hu ◽  
...  

Polylactic acid (PLA) has been extensively researched in biomedical engineering applications due to its superior mechanical strength and biocompatibility in vivo.


2013 ◽  
Vol 9 (8) ◽  
pp. 1139-1158 ◽  
Author(s):  
Peter Newman ◽  
Andrew Minett ◽  
Rutledge Ellis-Behnke ◽  
Hala Zreiqat

2021 ◽  
Author(s):  
Fan Liu ◽  
Honglei Kang ◽  
Zhiwei Liu ◽  
Siyang Jin ◽  
Guoping Yan ◽  
...  

Abstract Background: Biodegradable polymeric scaffolds are critical to repair a large bone defect, which can provide a porous and network microenvironment for cell attachment and bone tissue regeneration. A multifunctional biodegradable PCL/HA composite was prepared with the blending of poly(ε-caprolactone) (PCL) and hydroxyapatite nanoparticles (HA). Subsequently, the PCL/HA scaffolds implants were produced by the screw extrusion/melting deposition forming method using PCL/HA composite as a raw material in this work. Results: Through a serial of in vitro assessments, it is found that the PCL/HA composite possesses good biodegradability, good biocompatibility, and steady drug release performance, which can improve the cell proliferation of osteoblast cells MC3T3-E1. Meanwhile, in vivo experiments were carried out for the rats with skull defect and rabbits with bone defects. It is observed that the PCL/HA scaffolds implants allow the adhesion and penetration of bone cells, which enables the growth of bone cells and bone tissue regeneration. With a composite design to load an anticancer drug and achieve sustained drug release, the scaffolds could enhance bone repair and be expected to inhibit the tumor cells and improve patient outcomes. Conclusions: This work signifies that PCL/HA composite can be used as the potential biodegradable scaffolds for bone repairing after bone malignant tumor resection.


Nanomaterials ◽  
2019 ◽  
Vol 9 (10) ◽  
pp. 1501 ◽  
Author(s):  
Baoqing Pei ◽  
Wei Wang ◽  
Nicholas Dunne ◽  
Xiaoming Li

With advances in bone tissue regeneration and engineering technology, various biomaterials as artificial bone substitutes have been widely developed and innovated for the treatment of bone defects or diseases. However, there are no available natural and synthetic biomaterials replicating the natural bone structure and properties under physiological conditions. The characteristic properties of carbon nanotubes (CNTs) make them an ideal candidate for developing innovative biomimetic materials in the bone biomedical field. Indeed, CNT-based materials and their composites possess the promising potential to revolutionize the design and integration of bone scaffolds or implants, as well as drug therapeutic systems. This review summarizes the unique physicochemical and biomedical properties of CNTs as structural biomaterials and reinforcing agents for bone repair as well as provides coverage of recent concerns and advancements in CNT-based materials and composites for bone tissue regeneration and engineering. Moreover, this review discusses the research progress in the design and development of novel CNT-based delivery systems in the field of bone tissue engineering.


2008 ◽  
Vol 10 (2) ◽  
pp. 99-105 ◽  
Author(s):  
Giuseppe Polimeni ◽  
Ki-Tae Koo ◽  
Gordon A. Pringle ◽  
Alexis Agelan ◽  
Fayez F. Safadi ◽  
...  

Polymer Korea ◽  
2018 ◽  
Vol 42 (1) ◽  
pp. 99-105
Author(s):  
Jung-Hee Lee ◽  
Yoon Soo Han ◽  
Kyung Hye Jung ◽  
Young-Jin Kim

Sign in / Sign up

Export Citation Format

Share Document